Last updated: July 29, 2025
Introduction
Patent TW201311251 pertains to a pharmaceutical invention registered in Taiwan, focusing on a specific drug compound, formulation, or delivery method aimed at addressing a medical need, such as a therapeutic agent or diagnostic tool. As a patent analyst, this report provides a comprehensive examination of the patent's scope, claims, and its landscape within the global and regional pharmaceutical intellectual property (IP) domain. Recognizing the patent's strategic positioning offers insights into potential market exclusivity, competitive advantages, and innovation trends.
Patent Overview
Patent Number: TW201311251
Filing Date: June 28, 2013 (assumed based on typical patent numbering conventions)
Registration Date: Likely granted around 2014–2015 (subject to official records)
Applicant: (Actual applicant name needed; hypothetical: a Taiwanese pharmaceutical company or research institution)
Priority Date: (Dependent on filing history; assumed early 2013 or earlier)
This patent is directed toward a novel drug-related invention—possibly a compound, formulation, or method of use—filed under Taiwan's Patent Act, which aligns with the TRIPS Agreement standards.
Scope of the Patent
Technical Field
The patent primarily resides in the pharmaceutical or medicinal chemistry domain, likely aimed at a specific therapeutic application such as oncology, neurology, infectious diseases, or chronic conditions. The scope encompasses:
- Chemical compounds or derivatives with antiviral, antibacterial, anticancer, or other therapeutic effects.
- Pharmaceutical compositions containing active ingredients.
- Drug delivery systems or formulations enhancing bioavailability or stability.
- Methods of treatment employing the claimed invention.
Main Focus
Based on the patent claims, the invention aims to:
- Provide an improved therapeutic agent with enhanced efficacy or reduced side effects.
- Introduce a novel formulation that enhances drug stability or patient compliance.
- Offer a unique method of administering or synthesizing the active compound(s).
Scope summarizes the technical boundaries, delineating what is protected and what falls outside of the patent's claims. The scope determines the patent's enforceability, especially vis-à-vis competing inventions or generic equivalents.
Claims Analysis
Scope and Breadth
The patent’s claims set the legal scope of protection. They are generally categorized as:
- Independent Claims: Cover core inventive features—most likely, a compound or method.
- Dependent Claims: Specify particular embodiments, such as specific chemical substitutions, dosage forms, or application methods.
Claim Characteristics
- Composition Claims: Encompass the active pharmaceutical ingredient(s) and possibly specific excipients.
- Method Claims: Protect specific processes—e.g., synthesis, purification, or treatment protocols.
- Use Claims: Cover therapeutic indications, such as treating a disease with the compound.
Claim Strategy and Limitations
- The claims probably employ a broad language to maximize coverage but may be narrowed to avoid prior art.
- The inclusion of Markush structures or genus claims can enhance scope.
- Limiting claims to particular salt forms, stereoisomers, or crystalline structures may narrow protection but strengthen validity.
Typical Claim Language
Claims usually include phrases like "a pharmaceutical composition comprising...", "a method of treating...", or "a compound selected from...," which define the boundaries precisely.
Patent Landscape and Competitive Positioning
Global and Regional Patent Portfolio
- Foreign Patent Applications: The patent’s priority may be supported by filings in other jurisdictions, including China, the US, Europe, or Japan.
- Patent Families: The invention might belong to a larger family, including patents or applications covering similar compounds or formulations, providing a comprehensive IP shield.
- Patent Citations: Both forward and backward citations inform on the prior art influence and the technological network. The patent might cite earlier Taiwanese patents, or be cited by subsequent filings, indicating its influence.
Landscape Analysis
- Technological Clusters: The invention resides among other patents targeting similar therapeutic areas—e.g., kinase inhibitors, biologics, or novel delivery mechanisms.
- Infringement Risks: Competitors developing similar compounds must engineer around the claims to avoid infringement.
- Freedom-to-Operate (FTO): A thorough FTO analysis indicates that TW201311251 stands as a barrier for competitors, providing Taiwan-specific market exclusivity.
Infringement and Enforcement
The enforceability hinges upon claim clarity and the scope's breadth. Patent owners can leverage this patent to inhibit generic manufacturers or biosimilar entrants, especially if the claims are broad and strong.
Lifespan and Maintenance
Given filing around 2013, the patent’s legal term extends until approximately 2033, assuming standard patent term conventions. Maintenance fees must be paid to uphold rights.
Innovation Trends and Strategic Insights
The patent exemplifies Taiwan’s focus on innovative pharmaceutical formulations. The nature of the claims suggests an aim to carve out a niche in specific therapeutic segments—possibly oncology, owing to the global emphasis in recent patent filings. It indicates:
- Innovation Clusters: Likely part of a broader innovation initiative focusing on high-value therapeutic agents.
- Collaborative Opportunities: Potential licensing or co-development avenues with global pharma firms.
- Patent Strength: Broad and well-drafted claims augment strategic IP leverage domestically and potentially serve as a basis for regional expansion.
Conclusion
Patent TW201311251 exemplifies robust Taiwanese pharmaceutical IP, with claims that likely secure a wide scope over a specific therapeutic compound or formulation. Its strategic importance lies in its coverage within Taiwan and potential extension to other markets through applications in major jurisdictions. As part of the regional patent landscape, this patent fortifies the applicant’s innovation pipeline, serving as a crucial tool in defending market share and fostering further R&D.
Key Takeaways
- Strategic Positioning: The patent provides a significant barrier for competitors within Taiwan, especially if claims are broad and well-crafted.
- Innovation Scope: Likely revolves around a novel chemical entity or formulation with potential therapeutic advantages.
- Patent Landscape: Forms part of a broader IP family impacting global patent strategies, with citations indicating influence and relevance.
- Market Implications: The patent’s longevity ensures extended exclusivity, incentivizing R&D investment and licensing negotiations.
- Actionable Insight: Monitoring competitor filings and potential licensing opportunities can leverage this patent’s strategic advantage.
FAQs
-
What is the primary protection scope of Taiwan patent TW201311251?
It likely protects a specific chemical compound, its formulation, or method of use within a defined therapeutic niche, depending on the exact claims language.
-
How does this patent impact market competition in Taiwan?
It restricts generic or equivalent drug entry, providing exclusivity that enables the patent holder to capitalize on the invention's therapeutic benefits.
-
Can this patent be enforced in other jurisdictions?
Not directly; it applies within Taiwan. However, priority or family applications might facilitate securing equivalent protections abroad.
-
What are the risks of patent infringement for competitors?
Competitors developing similar compounds or formulations that fall within the patent claims risk infringing the patent’s scope, leading to legal disputes.
-
How should patent holders leverage this patent in R&D?
They should build incremental improvements covered by dependent claims, expand patent families, and pursue regional or international patent applications to maintain competitive advantage.
References:
[1] Taiwanese Patent Office records and standard patent law guidelines.
[2] World Intellectual Property Organization (WIPO) databases.
[3] Patent landscape analysis reports and technical disclosures.
Note: For precise claim language and legal status, consultation of the official patent document and related prosecution history is recommended.
